099430 — Bio Plus Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
KR₩373bn
Enterprise Value
KR₩426bn
Revenue
KR₩91bn

Annual balance sheet for Bio Plus Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	41,028	78,951	65,002	41,673	27,182
Net Total Accounts Receivable
Net Total Receivables	8,360	18,133	23,240	21,203	12,931
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	54,416	106,059	97,336	76,820	64,783
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	22,013	27,873	56,478	150,240	195,414
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	88,462	146,518	172,807	264,298	285,040
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7,499	9,477	10,964	112,328	77,305
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	9,762	33,253	44,990	130,811	110,197
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	78,699	113,265	127,817	133,487	174,843
Total Liabilities & Shareholders' Equity	88,462	146,518	172,807	264,298	285,040
Total Common Shares Outstanding